Back | Next |
home / stock / crmd / crmd message board
Subject | By | Source | When |
---|---|---|---|
best news of the day | Teivel | investorshub | 06/02/2023 11:34:36 AM |
short squeeze all day | now invest | investorshub | 06/01/2023 4:07:21 PM |
what does this mean? | namah sivaya | investorshub | 06/01/2023 10:19:57 AM |
are we finally gonna see some action | Teivel | investorshub | 05/30/2023 5:13:07 PM |
well.... hasn't been great.... but as of late... | now invest | investorshub | 05/11/2023 1:10:17 PM |
Could this has traded poorly since the announcement. | rosemountbomber | investorshub | 03/08/2023 12:45:57 PM |
I really don't like playing this when will | Lazerking40 | investorshub | 03/07/2023 1:25:51 PM |
News out AH today that the primary CMO | couldbebetter | investorshub | 03/02/2023 10:39:50 PM |
Moving nice today!!! Up 7.41%!! | now invest | investorshub | 03/01/2023 5:41:53 PM |
Let's hope Joe can get this across the | Lazerking40 | investorshub | 02/10/2023 2:07:52 PM |
Slowly creeping back up...... trying to. Just | now invest | investorshub | 02/03/2023 5:04:55 PM |
Price far below JMP target of 14 !!! | now invest | investorshub | 11/17/2022 6:01:50 PM |
CRMD broke over 4 today!!! Nice move.... | now invest | investorshub | 11/17/2022 5:58:53 PM |
reslabrat...thanks for the info...and best of luck to all | thumper1 | investorshub | 08/04/2022 5:48:05 PM |
Yeah, saw that. Good news for sure. | Lazerking40 | investorshub | 08/02/2022 5:34:51 PM |
NTAP Approval | reslabrat | investorshub | 08/02/2022 2:11:56 AM |
great news today...i bot more....burp | thumper1 | investorshub | 02/28/2022 8:08:32 PM |
Company announced resubmission of defencath NDA this morning. | tone3 | investorshub | 02/28/2022 4:28:39 PM |
CorMedix to Participate in Upcoming January Conferences | Yaafah | investorshub | 01/04/2022 5:11:16 PM |
At some point this will be FDA approved..the | Yaafah | investorshub | 12/18/2021 7:31:12 PM |
News, Short Squeeze, Breakout and More Instantly...
BERKELEY HEIGHTS, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that the Center for Medicare & Medicaid Service...
BERKELEY HEIGHTS, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced DefenCath® (taurolidine and heparin) catheter ...
BERKELEY HEIGHTS, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (NASDAQ:CRMD), a biopharmaceutical company focused on developing therap...